Tags:DrugMedicalMedTechTechnology
Ardelyx—Ardelyx™ seeks to develop therapeutics that act exclusively in the gastrointestinal tract and that are devoid of systemic exposure. Its drug candidates target important diseases, as well as pathologies with a specific inflammatory pathway. Its technology relies on non-absorbable small molecules with highly specific modes of action. www.ardelyx.com

Investors 1

Mentions in press and media 6

DateTitleDescriptionCategoryAuthorSource
14.04.2021Ardelyx Co... FREMONT, Calif. and WALTHAM,...--prnewswire...
12.04.2021Ardelyx An... FREMONT, Calif. and WALTHAM,...--prnewswire...
22.10.2020Ardelyx La... FREMONT, Calif., Oct. 22, 20...--prnewswire...
29.06.2016The biotec...There was a time af­ter the 2...FinancingJohn Carro...endpts.com...
31.08.2011 Amgen ...Amgen Ventures, the venture ca...--socaltech....
31.08.2011Ardelyx Cl...Ardelyx, Inc., a Fremont, Cali...funding U...-finsmes.co...